- •Primary aldosteronism (PA) is relatively common cause of difficult-to-control hypertension.
- •Unrecognized and untreated PA increases risk of cardiac and renal complications.
- •Initial workup of high-risk patients should include plasma aldosterone and renin levels.
- •Patients with elevated aldosterone and suppressed renin should be referred to specialty care.
- •Spironolactone is a drug of choice in treatment of bilateral adrenal hyperplasia.
Primary aldosteronism is relatively common cause of secondary difficult-to-control hypertension. It can be cured with either surgery or targeted medical therapy. Unfortunately, it is rarely recognized by primary care providers. Undiagnosed and untreated, primary aldosteronism increases risk of cardiovascular and renal complications. Primary care nurse practitioners are well positioned to identify patients at risk and initiate diagnostic workup of primary aldosteronism to improve clinical outcomes of patients with poorly controlled hypertension.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The Journal for Nurse Practitioners
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association.Hypertension. 2018; 72: e53-e90https://doi.org/10.1161/HYP.0000000000000084
- Endocrine hypertension: a primer for primary care nurse practitioners.J Nurse Pract. 2019; 15: 782-786
- Diagnosis and treatment of primary aldosteronism: practical clinical perspectives.J Intern Med. 2019; 285: 126-148https://doi.org/10.1111/joim.12831
- Diagnosis and treatment of primary aldosteronism.Lancet Diabetes Endocrinol. 2021; 9: 876-892https://doi.org/10.1016/S2213-8587(21)00210-2
- A young man with severe hypertension.BMJ. 2018; 362: k2935https://doi.org/10.1136/bmj.k2935
- Primary aldosteronism: a common cause of resistant hypertension.CMAJ. 2017; 189: 773-778https://doi.org/10.1503/cmaj.161486
Irina Benenson, DNP, FNP-C, is an associate professor, Advanced Nursing Division, Rutgers School of Nursing, Newark, NJ, and can be contacted at [email protected]
Kimberly Buff Prado, DNP, APN, is a clinical assistant professor, Advanced Nursing Practice Division, Rutgers School of Nursing, Newark, NJ.
Published online: August 15, 2022
Publication stageIn Press Corrected Proof
In compliance with standard ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.
© 2022 Elsevier Inc. All rights reserved.